Duarte Belmiro P M, Atkinson Anthony C
Polytechnic Institute of Coimbra, ISEC, Coimbra, Portugal.
INESC Coimbra, Universidade de Coimbra, Coimbra, Portugal.
J Biopharm Stat. 2024 Aug 31:1-18. doi: 10.1080/10543406.2024.2395548.
We study optimal designs for clinical trials when the value of the response and its variance depend on treatment and covariates are included in the response model. Such designs are generalizations of Neyman allocation, commonly used in personalized medicine when external factors may have differing effects on the response depending on subgroups of patients. We develop theoretical results for D-, A-, E- and D-optimal designs and construct semidefinite programming (SDP) formulations that support their numerical computation. D-, A-, and E-optimal designs are appropriate for efficient estimation of distinct properties of the parameters of the response models. Our formulation allows finding optimal allocation schemes for a general number of treatments and of covariates. Finally, we study frequentist sequential clinical trial allocation within contexts where response parameters and their respective variances remain unknown. We illustrate, with a simulated example and with a redesigned clinical trial on the treatment of neuro-degenerative disease, that both theoretical and SDP results, derived under the assumption of known variances, converge asymptotically to allocations obtained through the sequential scheme. Procedures to use static and sequential allocation are proposed.
当响应值及其方差取决于治疗方法且响应模型中包含协变量时,我们研究临床试验的最优设计。此类设计是奈曼分配的推广,在个性化医疗中常用,此时外部因素可能根据患者亚组对响应产生不同影响。我们推导了D -、A -、E -和D -最优设计的理论结果,并构建了支持其数值计算的半定规划(SDP)公式。D -、A -和E -最优设计适用于有效估计响应模型参数的不同属性。我们的公式允许为任意数量的治疗方法和协变量找到最优分配方案。最后,我们研究了响应参数及其各自方差仍未知情况下的频率主义序贯临床试验分配。我们通过一个模拟示例以及一个重新设计的神经退行性疾病治疗临床试验表明,在已知方差假设下得出的理论结果和SDP结果都渐近收敛于通过序贯方案获得的分配。文中提出了使用静态和序贯分配的程序。